PARLIAMENTARY WRITTEN QUESTION
Cancer: Radioisotopes (18 July 2022)

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the availability of shielded rooms in the NHS in the context of the potential increase in availability of (a) radioligand therapy and (b) other nuclear medicines to treat certain cancers.

Asked by:
Mohammad Yasin (Labour)

No specific assessment has been made. Further work is required on the safe delivery of the service with an appropriate number of providers to balance patient access with available specialist expertise and infrastructure.

Answered by:
James Morris (Conservative)
21 July 2022